ReachMD

Episodes 1-15 of 78

• • 

    

    Sara Hurvitz, MD

    Peer

  • 

    

    Tiffany Traina, MD

    Peer

  6

  

  RestartResume

  Advancements in Treatment Approaches for Triple-Negative Breast Cancer

• • 

    

    Charles Geyer, MD

    Peer

  7

  

  RestartResume

  Improving Outcomes in HER2+ Early Breast Cancer

• • 

    

    Omid Hamid, MD

    Peer

  • 

    

    Do-Youn Oh, MD, PhD

    Peer

  11

  

  RestartResume

  Biliary Tract Carcinoma: Are We at the Point of Change?

• • 

    

    Omid Hamid, MD

    Peer

  • 

    

    Susana M. Campos, MD, MPH

    Peer

  • 

    

    Robert L. Ferris, MD, PhD

    Peer

  7

  

  RestartResume

  The Growing Burden of HPV-Associated Cancers

• • 

    

    Mitesh J. Borad, MD

    Peer

  • 

    

    Milind Javel, MD

    Peer

  8

  

  RestartResume

  Rethinking Approaches to Biliary Tract Carcinoma

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Joshua Bauml, MD

    Peer

  2

  

  RestartResume

  Distilling Modern Medical Approaches in Advanced NSCLC: Precision, Performanc...

• • 

    

    Kenneth C. Anderson, MD

    Peer

  • 

    

    Philippe Moreau, MD

    Peer

  8

  

  RestartResume

  Real-World Treatment Effectiveness Compared with Clinical Trial Efficacy in M...

• • 

    

    Alfredo L. Falcone, MD

    Peer

  • 

    

    Sebastian Stintzing, MD

    Peer

  • 

    

    Tianshu Liu, MD

    Peer

  6

  

  RestartResume

  Clinical Considerations in Treatment Sequencing for mCRC

• • 

    

    Scott Kopetz, MD, PhD, FACP

    Peer

  • 

    

    Alberto Sobrero, MD

    Peer

  • 

    

    Rui-Hua Xu, MD

    Peer

  15

  

  RestartResume

  Melhorar a Prática Clínica na Gestão do mCRC: Ênfase no Lado do Tumor

• • 

    

    Scott Kopetz, MD, PhD, FACP

    Peer

  • 

    

    Alberto Sobrero, MD

    Peer

  • 

    

    Rui-Hua Xu, MD

    Peer

  15

  

  RestartResume

  Mejorar la práctica clínica en el tratamiento del CCRm: énfasis en la lateral...

• • 

    

    Scott Kopetz, MD, PhD, FACP

    Peer

  • 

    

    Alberto Sobrero, MD

    Peer

  • 

    

    Rui-Hua Xu, MD

    Peer

  19

  

  RestartResume

  Improving Clinical Practice in Management of mCRC: A Focus on Tumor Sidedness

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Philip A. Philip, MD, PhD, FRCP

    Peer

  • 

    

    Kurt Tauer, MD, FACP

    Peer

  12

  

  RestartResume

  The Evolution of Biomarker-Based Treatment in Metastatic Colorectal Cancer
• 43

  

  RestartResume

  Innovative Molecules in Immuno-Oncology: Revolutionizing Cancer Treatment

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Ronald DeMatteo, MD, FACS

    Peer

  13

  

  RestartResume

  What to Know About a State-of-the-Art Approach to GIST Treatment

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Robert Vonderheide, MD

    Peer

  22

  

  RestartResume

  CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

• 1
• 2
• 3
• …
• 5
• 6
• Next